Offering exceptional antigen-binding capabilities, AffiAB® Goat anti-NSP2 (SARS-CoV-2) Polyclonal IgG Antibody is a high-quality antibody for detection and analysis of SARS-CoV-2 virus particles. This goat polyclonal IgG antibody is highly specific to NSP2 (nucleocapsid protein) and displays excellent binding capacity to detect and analyze viral antigens.
The AffiAB® Goat anti-NSP2 (SARS-CoV-2) Polyclonal IgG Antibody is an antibody specifically designed to target and detect the NSP2 protein of the SARS-CoV-2 virus. NSP2, also known as non-structural protein 2, is one of the non-structural proteins encoded by the viral RNA of SARS-CoV-2.
This polyclonal antibody is produced by immunizing goats with purified NSP2 protein or a specific peptide sequence derived from NSP2. The resulting antibody is then purified from goat serum using various purification techniques to ensure high specificity and quality.
The AffiAB® Goat anti-NSP2 (SARS-CoV-2) Polyclonal IgG Antibody is widely used in research and diagnostic applications to study the SARS-CoV-2 virus. It can be utilized in techniques such as Western blotting, immunohistochemistry, immunofluorescence, and ELISA to detect and analyze the expression and localization of NSP2 in infected cells or patient samples.
By specifically targeting NSP2, this antibody enables researchers to investigate the function and role of this protein in the viral replication cycle and pathogenesis of SARS-CoV-2. Understanding NSP2 is important for unraveling the molecular mechanisms of viral replication, host-virus interactions, and the development of potential therapeutics or vaccines against COVID-19.
In summary, the AffiAB® Goat anti-NSP2 (SARS-CoV-2) Polyclonal IgG Antibody is a valuable tool for scientists studying the SARS-CoV-2 virus and its non-structural proteins. Its high specificity and sensitivity make it suitable for various research applications related to virology, immunology, and COVID-19 research.